Natural Grocers by Vitamin Cottage, Inc.
NGVC NYSE Retail-Grocery Stores Financials FY2016–FY2025
Last close · Oct 23, 2026
$31.46
2.8%What Natural Grocers by Vitamin Cottage, Inc. does
No business description yet.
- Legal name
- Natural Grocers by Vitamin Cottage, Inc.
- Fiscal year ends
- September 30, 2025
- Latest annual report
- 10-K · Dec 11, 2025
- Accession · CIK
- 0001437749-25-037556
0001547459
Revenue and margins
Natural Grocers by Vitamin Cottage, Inc. had $1.3B of revenue in fiscal 2025, up 7.2% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 16.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $24.1M in fiscal 2025, 1.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Natural Grocers by Vitamin Cottage, Inc. returned $11.0M to shareholders in fiscal 2025, 46% of free cash flow. The diluted share count rose 0.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Natural Grocers by Vitamin Cottage, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $23.7M | $12.0M | $18.3M | $8.9M | $17.1M |
| Debt incl. finance leases | $66.3M | $63.6M | $58.5M | $47.2M | $49.7M |
| Net debt / EBITDA | 0.7x | 0.9x | 0.7x | 0.5x | 0.3x |
| Debt / equity | 0.2x | 0.1x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 12.5x | 12.7x | 9.6x | 11.2x | 20.2x |
| Current ratio | 1.0x | 1.0x | 1.0x | 0.9x | 1.1x |
| Quick ratio | 1.0x | 1.0x | 1.0x | 0.9x | 1.1x |
| Total assets | $655M | $663M | $669M | $655M | $671M |
| Total liabilities | $512M | $507M | $498M | $481M | $458M |
| Shareholders' equity | $143M | $156M | $171M | $174M | $212M |
| Net debt (− = net cash) | $42.6M | $51.5M | $40.2M | $38.3M | $32.6M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | — | — | — | — | ✕ | ✓ | ✓ | ✓ | ✕ |
| Current ratio rose | — | ✓ | ✕ | ✕ | ✕ | ✕ | ✓ | ✕ | ✕ | ✓ |
| Share count didn't rise | — | ✓ | ✓ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ |
| Gross margin rose | — | ✕ | ✕ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Revenue rose relative to assets | — | ✓ | ✓ | ✕ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ |
| F-score | — / 3 | 6 / 8 | 6 / 8 | 3 / 8 | 5 / 8 | 6 / 9 | 8 / 9 | 7 / 9 | 7 / 9 | 7 / 9 |
| Accruals ratio | −6.1% | −11.7% | −10.0% | −8.8% | −9.2% | −5.0% | −2.8% | −6.2% | −6.0% | −1.3% |
| Altman Z'' | 2.89 | 2.82 | 2.93 | 2.96 | 1.32 | 1.03 | 1.14 | 1.21 | 1.26 | 1.93 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $705M | $769M | $849M | $904M | $1.0B | $1.1B | $1.1B | $1.1B | $1.2B | $1.3B |
| Gross profit | $202M | $212M | $226M | $239M | $283M | $292M | $305M | $327M | $365M | $398M |
| Operating income | $20.4M | $14.1M | $15.1M | $16.8M | $27.7M | $28.3M | $30.2M | $31.7M | $47.0M | $62.0M |
| Interest expense | $3.0M | $3.8M | $4.6M | $5.0M | $2.0M | $2.3M | $2.4M | $3.3M | $4.2M | $3.1M |
| Pretax income | $17.3M | $10.3M | $10.5M | $11.8M | $25.7M | $26.1M | $27.8M | $28.4M | $42.8M | $58.9M |
| Income tax | $5.9M | $3.4M | −$2.2M | $2.4M | $5.7M | $5.5M | $6.4M | $5.1M | $8.9M | $12.5M |
| Net income | $11.5M | $6.9M | $12.7M | $9.4M | $20.0M | $20.6M | $21.4M | $23.2M | $33.9M | $46.4M |
| Net income to common | $11.5M | $6.9M | $12.7M | $9.4M | $20.0M | $20.6M | $21.4M | $23.2M | $33.9M | $46.4M |
| Diluted EPS | $0.51 | $0.31 | $0.56 | $0.42 | $0.89 | $0.91 | $0.94 | $1.02 | $1.47 | $2.00 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| Cash flow | ||||||||||
| Cash from operations | $28.8M | $40.8M | $42.9M | $37.4M | $66.5M | $53.9M | $39.7M | $64.6M | $73.8M | $55.3M |
| Capital expenditure | $53.8M | $41.1M | $23.7M | $30.0M | $26.8M | $26.4M | $28.0M | $36.6M | $37.5M | $31.2M |
| Free cash flow | −$24.9M | −$0.3M | $19.2M | $7.4M | $39.8M | $27.5M | $11.7M | $28.0M | $36.2M | $24.1M |
| Depreciation and amortization | $25.5M | $29.5M | $29.4M | $29.0M | $31.2M | $29.6M | $27.9M | $28.9M | $30.9M | $31.8M |
| Stock-based compensation | $0.9M | $0.8M | $0.8M | $1.2M | $1.1M | $0.9M | $1.2M | $1.4M | $2.8M | $4.0M |
| Share buybacks | $0.8M | $0.3M | $0.6M | $0.0M | $0.0M | $0.0M | $0.0M | $0.2M | $0.0M | $0.0M |
| Dividends paid | — | — | $0.0M | $0.0M | $6.3M | $51.5M | $9.1M | $9.1M | $31.9M | $11.0M |
| Dividends and buybacks | $0.8M | $0.3M | $0.6M | $0.0M | $6.3M | $51.5M | $9.1M | $9.3M | $31.9M | $11.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $4.0M | $6.5M | $9.4M | $6.2M | $28.5M | $23.7M | $12.0M | $18.3M | $8.9M | $17.1M |
| Total debt | — | — | — | — | $0.0M | $23.7M | $15.7M | $7.7M | $0.0M | $0.0M |
| Finance lease liabilities | — | — | — | — | $42.3M | $42.6M | $47.9M | $50.8M | $47.2M | $49.7M |
| Current assets | $97.3M | $108M | $111M | $115M | $143M | $136M | $141M | $153M | $147M | $168M |
| Current liabilities | $66.5M | $71.6M | $79.7M | $83.3M | $129M | $134M | $138M | $154M | $164M | $159M |
| Property and equipment, net | $178M | $184M | $189M | $202M | $148M | $151M | $157M | $169M | $179M | $183M |
| Goodwill | $5.2M | $5.2M | $5.2M | $5.2M | $5.2M | $5.2M | $5.2M | $5.2M | $5.2M | $5.2M |
| Intangible assets | $0.4M | $0.5M | $0.5M | $5.3M | $5.3M | $6.6M | $8.9M | $8.9M | $8.3M | $6.6M |
| Total assets | $282M | $300M | $307M | $327M | $682M | $655M | $663M | $669M | $655M | $671M |
| Total liabilities | $156M | $166M | $160M | $170M | $509M | $512M | $507M | $498M | $481M | $458M |
| Shareholders' equity | $127M | $134M | $147M | $157M | $173M | $143M | $156M | $171M | $174M | $212M |
| Margins | ||||||||||
| Gross margin | 28.6% | 27.6% | 26.6% | 26.4% | 27.3% | 27.7% | 28.0% | 28.7% | 29.4% | 29.9% |
| Operating margin | 2.9% | 1.8% | 1.8% | 1.9% | 2.7% | 2.7% | 2.8% | 2.8% | 3.8% | 4.7% |
| EBITDA margin | 6.5% | 5.7% | 5.2% | 5.1% | 5.7% | 5.5% | 5.3% | 5.3% | 6.3% | 7.0% |
| Net margin | 1.6% | 0.9% | 1.5% | 1.0% | 1.9% | 1.9% | 2.0% | 2.0% | 2.7% | 3.5% |
| FCF margin | −3.5% | −0.0% | 2.3% | 0.8% | 3.8% | 2.6% | 1.1% | 2.5% | 2.9% | 1.8% |
| Returns | ||||||||||
| Return on capital | — | — | — | — | 14.9% | 15.7% | 14.5% | 16.2% | 22.5% | 25.0% |
| Return on capital employed | 9.4% | 6.2% | 6.6% | 6.9% | 5.0% | 5.4% | 5.7% | 6.1% | 9.6% | 12.1% |
| Return on equity | 9.1% | 5.3% | 9.0% | 6.2% | 12.1% | 13.0% | 14.3% | 14.2% | 19.7% | 24.0% |
| Return on assets | 4.1% | 2.4% | 4.2% | 3.0% | 4.0% | 3.1% | 3.2% | 3.5% | 5.1% | 7.0% |
| Return on tangible equity | 9.5% | 5.4% | 9.0% | 6.4% | 12.3% | 15.7% | 15.1% | 14.8% | 21.1% | 23.1% |
| Growth | ||||||||||
| Revenue growth | — | 9.0% | 10.4% | 6.4% | 14.7% | 1.8% | 3.2% | 4.7% | 8.9% | 7.2% |
| Net income growth | — | −39.9% | 83.7% | −25.6% | 112.5% | 2.9% | 3.8% | 8.8% | 46.0% | 36.9% |
| EPS growth | — | −39.2% | 80.6% | −25.0% | 111.9% | 2.2% | 3.3% | 8.5% | 44.1% | 36.1% |
| FCF growth | — | — | — | −61.7% | 440.7% | −30.7% | −57.7% | 140.6% | 29.2% | −33.5% |
| Share count change | — | −0.2% | −0.2% | 0.6% | 0.1% | 0.6% | 0.5% | 0.1% | 1.1% | 0.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | — | — | — | — | 0.2x | 0.7x | 0.9x | 0.7x | 0.5x | 0.3x |
| Debt / equity | — | — | — | — | 0.0x | 0.2x | 0.1x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 6.7x | 3.7x | 3.3x | 3.4x | 13.5x | 12.5x | 12.7x | 9.6x | 11.2x | 20.2x |
| Current ratio | 1.5x | 1.5x | 1.4x | 1.4x | 1.1x | 1.0x | 1.0x | 1.0x | 0.9x | 1.1x |
| Quick ratio | 1.5x | 1.5x | 1.4x | 1.4x | 1.1x | 1.0x | 1.0x | 1.0x | 0.9x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 7.6% | 5.3% | 2.8% | 3.3% | 2.6% | 2.5% | 2.6% | 3.2% | 3.0% | 2.3% |
| Stock comp / revenue | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.3% |
| Payouts / FCF | — | — | 3.0% | 0.0% | 15.9% | 186.9% | 77.8% | 33.1% | 88.0% | 45.7% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 6.0 | 6.0 | 3.0 | 5.0 | 6.0 | 8.0 | 7.0 | 7.0 | 7.0 |
| Altman Z'' | 2.9 | 2.8 | 2.9 | 3.0 | 1.3 | 1.0 | 1.1 | 1.2 | 1.3 | 1.9 |
| Accruals ratio | −6.1% | −11.7% | −10.0% | −8.8% | −9.2% | −5.0% | −2.8% | −6.2% | −6.0% | −1.3% |
Source: SEC EDGAR XBRL filings (CIK 0001547459). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
